Enhanced response to C225 of A431 tumor xenografts growing in irradiated tumor bed-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Enhanced response to C225 of A431 tumor xenografts growing in irradiated tumor bed

Published:2009-09 Issue:3 Volume:92 Page:383-387
ISSN:0167-8140
Container-title:Radiotherapy and Oncology
language:en
Short-container-title:Radiotherapy and Oncology

Author:

Riesterer Oliver,Mason Kathryn A.,Raju Uma,Yang Qiuan,Wang Li,Hittelman Walter N.,Ang K. Kian,Milas Luka

Publisher

Elsevier BV

Subject

Radiology Nuclear Medicine and imaging,Oncology,Hematology

Reference27 articles.

1. Microenvironmental transformations by VEGF- and EGF-receptor inhibition and potential implications for responsiveness to radiotherapy;Bussink;Radiother Oncol,2007

2. EGFR-targeted anti-cancer drugs in radiotherapy: preclinical evaluation of mechanisms;Baumann;Radiother Oncol,2007

3. Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck;Bonner;N Engl J Med,2006

4. Importance of maintenance therapy in C225-induced enhancement of tumor control by fractionated radiation;Milas;Int J Radiat Oncol Biol Phys,2007

5. Experimental evaluation of tumor bed effect for C3H mouse mammary carcinoma and for C3H mouse fibrosarcoma;Urano;Radiat Res,1971

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Multifaceted Interplay between Hormones, Growth Factors and Hypoxia in the Tumor Microenvironment;Cancers;2022-01-21

2. Microenvironment-driven intratumoral heterogeneity in head and neck cancers: clinical challenges and opportunities for precision medicine;Drug Resistance Updates;2022-01

3. Mechanisms of Cetuximab Resistance and How to Overcome It;Critical Issues in Head and Neck Oncology;2021

4. Consolidation cetuximab after concurrent triplet radiochemotherapy+cetuximab in patients with advanced head and neck cancer: A randomized phase II study;Radiotherapy and Oncology;2020-09

5. Synergistic Effect of Epidermal Growth Factor Receptor Inhibitors and Ionization Radiation in Cancer Treatment;Recent Patents on Anti-Cancer Drug Discovery;2017-11-20

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3